Recombinant Human CCL24 Protein，His

CCL24, also known as eotaxin-2, is a chemokine that plays a crucial role in the recruitment of eosinophils and other immune cells to sites of inflammation, particularly in allergic responses and asthma. Its importance in various physiological and pathological processes has attracted significant attention in the field of immunology and therapeutic development. Studies have shown that CCL24 is involved in tissue repair and remodeling, as well as in the pathogenesis of various diseases, including asthma, allergic rhinitis, and certain cancers. The recombinant protein form of CCL24 enables researchers to explore its biological functions, binding interactions with receptors, and potential therapeutic applications. By generating CCL24 through recombinant DNA technology, scientists can produce sufficient quantities for in-depth studies, facilitating investigations into its role in modulating immune responses and its potential as a target for drug development. Moreover, understanding the structural and functional properties of CCL24 may lead to innovative approaches to manipulate its activity, opening avenues for treatments that can mitigate inflammatory diseases and improve patient outcomes. Consequently, the research on CCL24 recombinant proteins not only advances our knowledge of chemokine biology but also holds promise for developing novel therapeutic strategies against various inflammatory conditions.